Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies ... To watch more expert insights and analysis on the latest market action, check out more Market ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

Any number of sequences can be linked to isolate records - these can be small contigs assembled from dideoxy sequencing through to whole genomes (complete or multiple contigs generated from parallel ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...

"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

Digital_Genome_Market1 The digital genome market is dominated by America owing increasing prevalence of chronic diseases like cancer and di ...